Literature DB >> 11325214

Oxygen toxicity: simultaneous measure of pentane and malondialdehyde in humans exposed to hyperoxia.

M N Loiseaux-Meunier1, M Bedu, C Gentou, D Pepin, J Coudert, D Caillaud.   

Abstract

In order to estimate cell damage caused by free radicals during oxygenotherapy, we investigated the time course of two markers of lipoperoxidation: pentane in breath and malondialdehyde (MDA) in blood during brief normobaric hyperoxia. Nine healthy subjects inhaled hydrocarbon-free air (HCFA) for 30 minutes, hydrocarbon-free 100% O2 (HCFO2) for 125 minutes and then HCFA for 70 minutes. After 15 minutes of washout with HCFA, ambient pentane was eliminated. After HCFO2, at T175 versus T30 (i.e., 145 min from the start of 100% HCFO2), pentane production increased (P< 0.05). MDA rose significantly at T155 min (i.e., 125 min from the start of HCFO2), versus T30 (P< 0.01). These results suggest that acute hyperoxia causes a moderate increase in lipid peroxidation in healthy subjects. The increase of pentane and MDA confirms that acute hyperoxia induces lipid peroxidation in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325214     DOI: 10.1016/s0753-3322(01)00042-7

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  Adiponectin protects against hyperoxic lung injury and vascular leak.

Authors:  Sean M Sliman; Rishi B Patel; Jason P Cruff; Sainath R Kotha; Christie A Newland; Carrie A Schrader; Shariq I Sherwani; Travis O Gurney; Ulysses J Magalang; Narasimham L Parinandi
Journal:  Cell Biochem Biophys       Date:  2013-11       Impact factor: 2.194

2.  Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report.

Authors:  Thomas L Croxton; William C Bailey
Journal:  Am J Respir Crit Care Med       Date:  2006-04-13       Impact factor: 21.405

Review 3.  Oxygen therapy in chronic obstructive pulmonary disease.

Authors:  Victor Kim; Joshua O Benditt; Robert A Wise; Amir Sharafkhaneh
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 4.  Wound healing essentials: let there be oxygen.

Authors:  Chandan K Sen
Journal:  Wound Repair Regen       Date:  2009 Jan-Feb       Impact factor: 3.617

5.  Pulmonary Oxygen Toxicity in Navy Divers: A Crossover Study Using Exhaled Breath Analysis After a One-Hour Air or Oxygen Dive at Nine Meters of Sea Water.

Authors:  Thijs T Wingelaar; Pieter-Jan A M van Ooij; Paul Brinkman; Rob A van Hulst
Journal:  Front Physiol       Date:  2019-01-25       Impact factor: 4.566

6.  Markers of Pulmonary Oxygen Toxicity in Hyperbaric Oxygen Therapy Using Exhaled Breath Analysis.

Authors:  T T Wingelaar; P Brinkman; P J A M van Ooij; R Hoencamp; A H Maitland-van der Zee; M W Hollmann; R A van Hulst
Journal:  Front Physiol       Date:  2019-04-24       Impact factor: 4.566

7.  Exhaled Volatile Organic Compounds Precedes Pulmonary Injury in a Swine Pulmonary Oxygen Toxicity Model.

Authors:  William A Cronin; Angela S Forbes; Kari L Wagner; Peter Kaplan; Renee Cataneo; Michael Phillips; Richard Mahon; Aaron Hall
Journal:  Front Physiol       Date:  2019-12-03       Impact factor: 4.566

8.  Differential Response of Pentanal and Hexanal Exhalation to Supplemental Oxygen and Mechanical Ventilation in Rats.

Authors:  Lukas M Müller-Wirtz; Daniel Kiefer; Joschua Knauf; Maximilian A Floss; Jonas Doneit; Beate Wolf; Felix Maurer; Daniel I Sessler; Thomas Volk; Sascha Kreuer; Tobias Fink
Journal:  Molecules       Date:  2021-05-07       Impact factor: 4.411

9.  Hyperoxia promotes polarization of the immune response in ovalbumin-induced airway inflammation, leading to a TH17 cell phenotype.

Authors:  Akinori C Nagato; Frank S Bezerra; André Talvani; Beatriz J Aarestrup; Fernando M Aarestrup
Journal:  Immun Inflamm Dis       Date:  2015-06-18

10.  The effect of supplemental oxygen on perioperative brain natriuretic peptide concentration in cardiac risk patients - a protocol for a prosprective randomized clinical trial.

Authors:  Christian Reiterer; Barbara Kabon; Markus Falkner von Sonnenburg; Patrick Starlinger; Alexander Taschner; Oliver Zotti; Julius Goshin; Gregor Drlicek; Edith Fleischmann
Journal:  Trials       Date:  2020-05-12       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.